ATDBio joins Innovate UK EDGE Scaleup Programme to drive global growth
ATDBio, a leader in complex oligonucleotide synthesis, is pleased to announce that it has joined the Innovate UK EDGE Scaleup Programme. The Scaleup Programme supports a select group of companies on a journey to exponential growth. The initiative will help ATDBio scale up its world leading technology innovations for the rapidly growing oligonucleotide synthesis market.
The programme is designed to support highly innovative, ambitious, high-growth oriented companies already on their scaling journey, whose innovations or business models can disrupt an existing market, and who are establishing or already implementing their international markets strategy. High-impact engagement and early stage outcomes can include access to finance, investment readiness or internationalisation plans.
At the centre of the service is a team of high calibre scaleup directors who operate together as a board and provide each of the companies on the programme with a matrix of skills and connectivity. The scaleup directors will help ATDBio to structure itself for global growth and work with the company to understand the particular set of needs that it faces on its scaling journey.
Dr Tom Brown Jnr, Chief Scientific Officer of ATDBio, said 'ATDBio is proud to have been accepted, following a rigorous three-stage screening process. The potential of our business has developed significantly during the pandemic, and we are pleased to have support from the Innovate UK EDGE Scaleup Programme to help us realise these new opportunities.'
Maxine Adam, Head of Business Growth at Innovate UK, said, 'Our work with the ATDBio team is a great example of just how much value this programme can add to the endeavours of the business leaders we support. The inputs are varied and blend strategic thinking with invaluable hands-on tactical guidance, to create outcomes that deliver real commercial advantage. It’s a pleasure working with the ATDBio Directors at this pivotal time for their business.'
Speaking about the programme, she added, 'Admission onto the Scaleup Programme is a rigorous and highly selective process. To be eligible, selectors look for innovative, ambitious, high-growth oriented companies that are already on their scaling journey. ATDBio is a perfect candidate in this respect and, together with EEN, we are looking forward to helping it scale up, drive growth, and realise its potential as a high-performing and world leading business'.